(MNTA)—Initial feedback to FDA’s draft guidance on interchangeable FoBs is coming in: http://raps.org/Regulatory-Focus/News/2017/04/04/27266/FDA%E2%80%99s-Draft-Biosimilar-Interchangeability-Guidance-Stakeholders-Seek-More-Clarity/ The deadline for submitting comments is 5/19/17.